© Copyright 2025 American Medical Association. All rights reserved.
A tissue cultured allogeneic dermal substitute is a specialized medical product used in the treatment of wounds or skin defects on the trunk, arms, or legs. This substitute is derived from human fibroblast cells, which are essential components of the skin that help in the formation of connective tissue. The fibroblasts are typically sourced from newborn foreskin tissue, ensuring a high level of viability and functionality. These cells are cultured and multiplied in a laboratory setting, where they are seeded onto a bioabsorbable mesh scaffold. This scaffold serves as a temporary structure that supports the fibroblasts as they grow and proliferate. As the fibroblasts multiply, they produce and secrete important substances such as human dermal collagen, matrix proteins, growth factors, and cytokines. These substances play a crucial role in wound healing and tissue regeneration by regulating the immune response and promoting the repair of damaged skin. The application of the dermal substitute involves careful preparation of the wound bed, followed by the placement of the substitute, which is then secured using sutures or staples to ensure it remains in position. After the dermal substitute is applied, a layered dressing is utilized to protect the area. This dressing typically consists of a nonadherent layer to prevent sticking to the wound, a bulky layer of gauze to absorb any exudate, a compression layer to support the area, and an anti-shear layer to minimize friction. The CPT® Code 15360 is specifically designated for the use of this dermal substitute when covering the first 100 square centimeters or less of skin area in adults, or up to 1% of the total body surface area in infants and children. For cases requiring additional coverage, CPT® Code 15361 is used for each subsequent 100 square centimeters or 1% of total body surface area.
© Copyright 2025 Coding Ahead. All rights reserved.
The tissue cultured allogeneic dermal substitute is indicated for use in various clinical scenarios where there is a need to cover wounds or skin defects on the trunk, arms, or legs. The following conditions may warrant the application of this procedure:
The procedure for applying a tissue cultured allogeneic dermal substitute involves several critical steps to ensure effective treatment and optimal healing outcomes. The following procedural steps are outlined:
Post-procedure care is essential to ensure proper healing and to monitor for any complications. After the application of the tissue cultured allogeneic dermal substitute, the patient should be advised on how to care for the dressing and the wound site. Regular follow-up appointments may be necessary to assess the healing process and to change the dressings as needed. It is important to monitor for signs of infection, such as increased redness, swelling, or discharge from the wound site. The healthcare provider may also provide specific instructions regarding activity restrictions to avoid undue stress on the healing area. Overall, the expected recovery will depend on the individual patient's condition and the extent of the wound being treated.
Short Descr | APPLY CULT DERM SUB T/A/L | Medium Descr | TISSUE CLTR ALGC DRM TRUNK/ARM/LEG 1ST 100 CM | Long Descr | Tissue cultured allogeneic dermal substitute, trunk, arms, legs; first 100 sq cm or less, or 1% of body area of infants and children | Status Code | Active Code | Global Days | 090 - Major Surgery | PC/TC Indicator (26, TC) | 0 - Physician Service Code | Multiple Procedures (51) | 2 - Standard payment adjustment rules for multiple procedures apply. | Bilateral Surgery (50) | 0 - 150% payment adjustment for bilateral procedures does NOT apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 1 - Statutory payment restriction for assistants at surgery applies to this procedure... | Co-Surgeons (62) | 0 - Co-surgeons not permitted for this procedure. | Team Surgery (66) | 0 - Team surgeons not permitted for this procedure. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Discontinued Code | Type of Service (TOS) | 2 - Surgery | Berenson-Eggers TOS (BETOS) | P5A - Ambulatory procedures - skin | MUE | Not applicable/unspecified. | CCS Clinical Classification | 172 - Skin graft |
Get instant expert-level medical coding assistance.